ANALYSIS OF PRESCRIPTION TREND IN THE TREATMENT OF HEPATITIS C AND THE STUDY OF ASSOCIATION OF THIS THERAPY PLAN WITH THE AGE OF THE PATIENT
Keywords:
Ribavirin, prescription, sofosbuvir, therapyAbstract
Objective: To check out the prescription trend for the hepatitis C i.e. to analyze the combination therapy. The association of therapy plan with the age of the patient was also studied.
Material and Methods: Prescriptions were collected from 97 patients diagnosed with hepatitis C from December 2016 to February 2017. Statistical calculations were carried out on these prescriptions to analyze the trend and to see the association of therapy plan with the age of the patient.
Results: In the prescription trend the combination of ribavirin 1200mg/day (400mg TID) and sofosbuver 400mg/day was found to be the most frequent. Second frequent therapy was the combination of oral therapeutic agent (ribavirin 1200mg/day (400mg TID)) and an injectable (Peginterferonalfa 2a) whereas interferon alfa 2a were also used along with the ribavirin. There was no association found between age of the patient and the therapy plan.
Conclusion: Oral therapy for the hepatitis C treatment is the most frequent therapy plan in the Jinnah hospital where as the second frequent therapy plan was a combination of oral and the injectable. On the other hand there is no association of age of patient with the therapy plan followed for hepatitis C.
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
